This study enrolls people who have been diagnosed with Tricuspid Regurgitation (TR). The purpose of this study is to look at the safety and effectiveness of this new investigational device compared to the standard medical treatment. Read More

Adults ages 18+
Diagnosed with Tricuspid Regurgitation/Insufficiency

This is a 26-week open-label study to evaluate the safety and effectiveness of the study drug in the treatment of pediatric participants with schizophrenia or bipolar I disorder. Read More

Males and females ages 13 to 18 with schizophrenia or 10 to 18 years of age with bipolar I disorder may be eligible for the study.

This study enrolls children and young adults with congenital anomalies of the kidney and urinary tract (CAKUT). The purpose of the study is to learn which gene mutation(s) may be responsible for this condition and to eventually find a gene therapy to treat this condition. Read More

Children and young adults ages 0-21 years old with CAKUT (congenital anomalies of the kidney and urinary tract) seen at Oshei Children's Hospital
Patient's family member without CAKUT.

The purpose of this study is to develop a device to help people after they have had a stroke. This study looks at how the wrist moves when a person does everyday activities. Read More

-Adults ages 18-65.
-Healthy and fit to perform active daily living tasks.

This study enrolls people who have had a brain aneurysm who will be treated with endovascular coil embolization. This procedure blocks blood flow to the bulging blood vessel in the brain. The purpose of this study is to learn how well SMART COIL System works for this type of procedure in everyday practice. The system is cleared by the FDA. Read More

Adults ages 18+.
Will be having embolization of intracranial aneurysms procedure.

This study enrolls adults who work in a pharmacy that is part of the Community Pharmacy Enhanced Services Network (CPESN). The purpose of this study is to learn about if it would be feasible to make a Community Heath Worker (CHW) program embedded within a pharmacy practice. Read More

Adults ages 18+.
Staff member in a pharmacy that is part of the Community Pharmacy Enhanced Services Network (CPESN) in New York and Missouri. Some of these pharmacies are implementing community health worker programs focused on patients with chronic health issues.
People eligible to participate in this study will be directly contacted by the study staff.

This study enrolls people who have have had a kidney transplant in the past year. The purpose of this study is to learn about outcomes in kidney Read More

Adults ages 18+.
Recipient of a kidney transplant.
At least 1 year post-transplant (+/- 2 months).
Selected by provider to undergo TruGraf® testing as part of post-transplant care.

This study enrolls older adults who may have a completely or partially blocked blood vessel(s) in their heart causing a type of heart attack known as a ST-elevation myocardial infarction (STEMI). This may need a medical procedure called “Percutaneous Coronary Intervention (PCI)” to open narrowed or blocked blood vessel(s). This is sometimes called an angioplasty or ‘balloon procedure’ often with stent placement at the same time. The purpose of this study is to learn about the safety and benefits of different types of treatment for this condition. Read More

Adults ages 60+.
You have had a significant ST-elevation myocardial infarction or left bundle branch block (LBBB).
Your physician plans to perform trans-radial Percutaneous Coronary Intervention (PCI).

This study enrolls people with Congenital Adrenal Hyperplasia (CAH), a rare condition that changes the body’s ability to create key hormones. To replace these important hormones, people who live with CAH need to take constant doses of steroids, which mimic hormones and help the body function. The purpose of this study is to learn about how safe and effective a non-steroid option is to treat CAH. Read More

Adults ages 18-55
Has a diagnosis of Classic Congenital Adrenal Hyperplaysia due to 21-hydroxylase deficiency
You'll have been on a stable daily dose of steroids (glucocorticoids or mineralocorticoid) before starting the trial.
Please contact the study team for additional eligibility criteria.

This study enrolls adults who have had a stroke. The purpose of the study is to learn whether the Q Revascularization System is safe and effective for removing the clot from the brain. Read More

Adults ages 18+.
Have had a disabling stroke.